Project ID: D2014-15IP Status: Provisional patent #62/115,786Invention Description: Methods of generating and administering digestion products of FDA-approved low acyl gellan gum (LA-GAGR) to produce mega-GAGR, midi-GAGR, and mini-GAGR and administration thereof. Applications: Compositions compris.....
[更多]
Novel hybrid material containing amino acid sequences derived from silkworm protein and synthetic nonpeptide chains.
[更多]
Executive Summary Alzheimers’ disease (AD), the leading cause of dementia is a very complex disorder with a variety of molecular and cellular pathological alterations. For many patients, the current pharmacological treatment proves ineffective. Current research suggests that changes in the polyamine.....
[更多]
Through a joint collaboration, the inventorshave synthesized and tested novel non-benzodiazepine GABAA receptorligands functionally selective to the alpha 6 subtype (α6GABAAR).Recent studies have implicated the α6GABAARs as the valid target intrigeminal orofacial pain, neuropsychiatric disorders wit.....
[更多]
Lead Inventors: Richard T. Ambron, Ph.D.Problem or Unmet Need:Cancer is the second leading cause of mortality in the United States and continues to grow as a major health concern in the developing world. A distinguishing hallmark of cancer is the uncontrollable proliferation and growth of malignant .....
[更多]
| |< <- | [6505] [6506] [6507] [6508] [6509] [6510] [6511] [6512] [6513] [6514] [6515] | -> >| |
